GreenLab utilizes patented corn biotechnology to produce proteins and enzymes at scale, transforming cornfields into a sustainable source for various industries. Their recombinant manganese peroxidase offers a cost-effective solution for environmental remediation, addressing the need for efficient degradation of complex organic pollutants.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for producing proteins and enzymes at scale are often unsustainable and costly, hindering the development of environmentally friendly and economically viable solutions for various industries. Traditional production methods struggle to meet the growing demand for proteins and enzymes in sectors like environmental remediation, food, and manufacturing.
Solution
GreenLab leverages patented corn biotechnology to transform cornfields into a sustainable and scalable platform for protein and enzyme production. Their technology enables the cost-effective production of recombinant proteins and enzymes, addressing the limitations of traditional methods. GreenLab's initial focus is on brazzein, a natural high-intensity sweet protein, and manganese peroxidase (MnP), an enzyme used for environmental remediation. GreenLab's MnP offers a commercially viable solution for degrading complex organic pollutants, which are often resistant to other degradation methods.
Target Audience
GreenLab targets partners in protein design, enzyme engineering, and biomanufacturing across various industries, including energy, food, pharmaceuticals, nutraceuticals, environmental, and industrial sectors.
Features
- Patented corn-based protein production platform
- Production of brazzein, a natural high-intensity sweet protein for food applications
- Recombinant manganese peroxidase (MnP) for environmental remediation
- Scalable production of proteins and enzymes in corn seeds
- Cost-effective alternative to traditional protein and enzyme production methods